Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response.
作者信息
Kuwabara Aya, Babb Anna, Ibrahim Amr, Milojkovic Dragana, Apperley Jane, Bua Marco, Reid Alistair, Foroni Letizia, Rezvani Katayoun, Goldman John, Marin David
出版信息
Blood. 2010 Aug 12;116(6):1014-6. doi: 10.1182/blood-2010-04-280206.
Abstract
摘要
相似文献
1
Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response.因妊娠中断治疗且未获得最佳反应的慢性髓性白血病患者重新引入伊马替尼后预后较差。
Blood. 2010 Aug 12;116(6):1014-6. doi: 10.1182/blood-2010-04-280206.
2
Pregnancy in patients with chronic myeloid leukemia treated with imatinib.接受伊马替尼治疗的慢性髓性白血病患者的妊娠情况。
Leuk Lymphoma. 2007 Dec;48(12):2454-6. doi: 10.1080/10428190701658751.
3
Successful outcome of pregnancy in chronic myeloid leukaemia treated with imatinib.伊马替尼治疗慢性髓性白血病后成功妊娠的结果
Leuk Lymphoma. 2004 Jun;45(6):1307-8. doi: 10.1080/10428190310001645195.
4
Pregnancy outcome of two patients treated with imatinib.两名接受伊马替尼治疗患者的妊娠结局
Ann Oncol. 2005 Dec;16(12):1983-4. doi: 10.1093/annonc/mdi398. Epub 2005 Aug 12.
5
Successful childbirth in a patient with chronic myelogenous leukemia treated with imatinib mesylate during early pregnancy.一名在妊娠早期接受甲磺酸伊马替尼治疗的慢性粒细胞白血病患者成功分娩。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008 Jun;152(1):121-3. doi: 10.5507/bp.2008.019.
6
[Evolution of chronic myeloid leukemia on nilotinib after failure of imatinib].伊马替尼治疗失败后慢性髓性白血病患者使用尼罗替尼的病情演变
Pan Afr Med J. 2014 Jun 17;18:142. doi: 10.11604/pamj.2014.18.142.3308. eCollection 2014.
7
Discontinuing imatinib in chronic myeloid leukemia: don't try this at home.慢性粒细胞白血病中停用伊马替尼：请勿在家自行尝试。
Leuk Lymphoma. 2009 Jun;50(6):868-70. doi: 10.1080/10428190902934951.
8
Position paper on imatinib mesylate in chronic myeloid leukaemia.关于甲磺酸伊马替尼治疗慢性髓性白血病的立场文件。
Br J Haematol. 2002 Oct;119(1):268-72. doi: 10.1046/j.1365-2141.2002.39201.x.
9
Successful outcome of pregnancy in a patient with chronic myelogenous leukemia exposed to imatinib during the first trimester.
Leuk Lymphoma. 2006 Jun;47(6):1149-50. doi: 10.1080/10428190500399029.
10
Successful delivery after planned discontinuation of imatinib in a patient with chronic myeloid leukemia.
Intern Med. 2009;48(5):369-71. doi: 10.2169/internalmedicine.48.1687. Epub 2009 Mar 2.
引用本文的文献
1
Management of CML and Pregnancy in Low-and Middle-income Countries.低收入和中等收入国家慢性粒细胞白血病与妊娠的管理
Indian J Hematol Blood Transfus. 2025 Jan;41(1):1-9. doi: 10.1007/s12288-024-01930-8. Epub 2024 Nov 19.
2
[The guidelines for diagnosis and treatment of chronic myelogenous leukemia in China (2020 edition)].《中国慢性髓性白血病诊断与治疗指南（2020年版）》
Zhonghua Xue Ye Xue Za Zhi. 2020 May 14;41(5):353-364. doi: 10.3760/cma.j.issn.0253-2727.2020.05.001.
3
Deep molecular responses for treatment-free remission in chronic myeloid leukemia.慢性髓性白血病无治疗缓解的深度分子反应
Cancer Med. 2016 Sep;5(9):2398-411. doi: 10.1002/cam4.801. Epub 2016 Jul 1.
4
The role of stem cell transplantation for chronic myelogenous leukemia in the 21st century.21世纪干细胞移植在慢性粒细胞白血病治疗中的作用。
Blood. 2015 May 21;125(21):3230-5. doi: 10.1182/blood-2014-10-567784. Epub 2015 Apr 7.
5
Chronic myeloid leukemia: advances in understanding disease biology and mechanisms of resistance to tyrosine kinase inhibitors.慢性髓性白血病：疾病生物学及对酪氨酸激酶抑制剂耐药机制认识的进展
Curr Hematol Malig Rep. 2015 Jun;10(2):158-66. doi: 10.1007/s11899-015-0248-3.
6
Pregnancy outcome in chronic myeloid leukemia patients on imatinib therapy.接受伊马替尼治疗的慢性髓性白血病患者的妊娠结局。
Ir J Med Sci. 2015 Mar;184(1):183-8. doi: 10.1007/s11845-014-1084-5. Epub 2014 Mar 4.
7
Recent advances in the path toward the cure for chronic myeloid leukemia.慢性髓性白血病治疗道路上的最新进展。
Korean J Hematol. 2011 Sep;46(3):169-74. doi: 10.5045/kjh.2011.46.3.169. Epub 2011 Sep 30.
本文引用的文献
1
Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.慢性髓性白血病：欧洲白血病网络概念与管理建议的更新
J Clin Oncol. 2009 Dec 10;27(35):6041-51. doi: 10.1200/JCO.2009.25.0779. Epub 2009 Nov 2.
2
Previous best responses can be re-achieved by resumption after imatinib discontinuation in patients with chronic myeloid leukemia: implication for intermittent imatinib therapy.慢性髓性白血病患者停用伊马替尼后重新开始治疗可再次达到既往最佳反应：对伊马替尼间歇治疗的启示
Leuk Lymphoma. 2009 Jun;50(6):944-51. doi: 10.1080/10428190902926973.
3
The effects of imatinib on pregnancy outcome.伊马替尼对妊娠结局的影响。
Blood. 2008 Jun 15;111(12):5505-8. doi: 10.1182/blood-2007-10-114900. Epub 2008 Mar 5.
4
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.接受伊马替尼治疗的慢性髓性白血病患者的五年随访
N Engl J Med. 2006 Dec 7;355(23):2408-17. doi: 10.1056/NEJMoa062867.
5
Pregnancy among patients with chronic myeloid leukemia treated with imatinib.接受伊马替尼治疗的慢性髓性白血病患者的妊娠情况。
J Clin Oncol. 2006 Mar 1;24(7):1204-8. doi: 10.1200/JCO.2005.04.6557. Epub 2006 Jan 30.
Zotero 插件